The global pharmaceutical contract sales outsourcing (CSO) market offers sales and marketing outsourcing services to pharmaceutical and biotechnology companies. CSO aims to boost sales performance and optimize sales operations cost by leveraging outsourced sales teams. Pharmaceutical CSO companies provide multi-channel engagement approaches through field sales teams, tele-detailing, and medical liaisons.

The global pharmaceutical contract sales outsourcing market is estimated to be valued at US$ 8,599.2 Mn in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Pharmaceutical Contract Sales Outsourcing Size are IQVIA Inc., Syneos Health Inc., Parexel International Corporation, PPD, ICON plc, Publicis Touchpoint Solutions, Inc., PRA Health Sciences, Inc., The Medical Affairs Company (TMAC), Ashfield Healthcare Communications Group, and GTS Solutions. These players are focusing on geographical expansion and providing specialized services to strengthen their market position.

North America Dominates Pharmaceutical CSO Market

North America currently dominates the global Pharmaceutical CSO market in terms of value, attributed to well-established pharmaceutical industries and advanced healthcare systems within the region. The presence of many large pharmaceutical companies and emerging biotech firms has been boosting the demand for outsourcing non-core sales operations. Moreover, the growing adoption of specialty medicine has increased the need for medical experts to detail products directly with healthcare providers. This is contributing to the higher uptake of CSO services including field forces, medical education and tele-detailing sales. The U.S. accounts for majority share of the North American as well as global Pharmaceutical CSO market value.

Asia Pacific is Fastest Growing Region for Pharmaceutical CSO Market

Asia Pacific region is expected to exhibit fastest growth in the global Pharmaceutical CSO market during the forecast period. This can be attributed to increasing healthcare expenditures, quick expansion of pharmaceutical industries and rising focus on specialty medicines in emerging countries like China, India and South Korea. Furthermore, widening patient access to drugs along with strengthening healthcare infrastructure is anticipated to propel the demand for CSO providers' expertise in sales operations from domestic pharmaceutical firms. Additionally, outsourcing sales activities helps small to mid-size Asia Pacific pharmaceutical companies to compete more effectively through cost optimization and enhanced commercialization. These factors would continue driving the Asia Pacific Pharmaceutical CSO market exponentially.

Gets More Insights on: Global Pharmaceutical Contract Sales Outsourcing Market

Explore More related Topic: Volumetric Displays